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Abstract
Intercellular transfer of microRNAs can mediate communication between critical effector cells. 
We hypothesized that transfer of neutrophil-derived microRNAs to pulmonary epithelial cells 
could alter mucosal gene expression during acute lung injury. Pulmonary-epithelial microRNA 
profiling during coculture of alveolar epithelial cells with polymorphonuclear neutrophils (PMNs) 
revealed a selective increase in lung epithelial cell expression of microRNA-223 (miR-223). 
Analysis of PMN-derived supernatants showed activation-dependent release of miR-223 and 
subsequent transfer to alveolar epithelial cells during coculture in vitro or after ventilator-induced 
acute lung injury in mice. Genetic studies indicated that miR-223 deficiency was associated with 
severe lung inflammation, whereas pulmonary overexpression of miR-223 in mice resulted in 
protection during acute lung injury induced by mechanical ventilation or by infection with 
Staphylococcus aureus. Studies of putative miR-223 gene targets implicated repression of 
poly(adenosine diphosphate-ribose) polymerase–1 (PARP-1) in the miR-223–dependent 
attenuation of lung inflammation. Together, these findings suggest that intercellular transfer of 
miR-223 from neutrophils to pulmonary epithelial cells may dampen acute lung injury through 
repression of PARP-1.
INTRODUCTION
Acute lung injury manifests as acute respiratory distress syndrome (ARDS) in patients (1). 
Its clinical features include acute hypoxemic respiratory failure and bilateral pulmonary 
infiltrates that are not attributable to left heart failure (1–3). During acute lung injury, 
inflammatory cells, particularly polymorphonuclear neutrophils (PMNs), come into close 
contact with lung alveolar epithelial cells.
Many research studies have provided insights into intercellular communications regulating 
neutrophil activation and pulmonary transmigration during acute lung injury (4). These 
communications include paracrine cross-talk between neutrophils and lung parenchymal 
cells. For example, previous studies have shown that PMNs release extracellular nucleotides 
Neudecker et al. Page 2
Sci Transl Med. Author manuscript; available in PMC 2018 September 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
(for example, adenosine triphosphate) that are converted into adenosine, which dampens 
pulmonary epithelial inflammation (5, 6) and improves fluid transport during acute lung 
injury (7,8). Here, we investigated whether PMNs could participate in intercellular 
communication with lung alveolar epithelial cells through microvesicle-dependent exchange 
of microRNAs (miRNAs) (9).
miRNAs constitute a family of short noncoding RNA molecules of 20 to 25 nucleotides in 
length that regulate gene expression at the post-transcriptional level (10). Bioinformatic 
predictions indicate that more than 60% of all mammalian genes are potentially regulated by 
miRNAs (11). Although the investigation of functional miRNA target genes has identified 
putative regulatory functions for miRNAs (12), little is known about the repression of 
inflammatory genes by miRNAs during acute lung injury. Here, we investigated whether 
PMN–epithelial cell crosstalk during acute lung inflammation could include the exchange of 
miRNAs (12).
RESULTS
miR-223 can be transferred from neutrophils to pulmonary epithelial cells
Previous studies have indicated that neutrophil (PMN)–epithelial cell cross-talk can dampen 
inflammation (13). On the basis of these findings, we hypothesized that during neutrophil–
epithelial cell interactions, genetic information in the form of miRNAs could be transferred 
from PMNs to pulmonary epithelia. To test this hypothesis, we set up an in vitro coculture 
system of human primary alveolar epithelial cells (HPAEpiC) with freshly isolated human 
PMNs, where both cell types were separated by a membrane with a pore size of 0.4 μm, 
preventing direct cell-cell contact (Fig. 1A). After 6 hours of coincubation, we washed the 
alveolar epithelial cells, isolated miRNAs, and performed a targeted expression analysis of 
miRNAs known to be expressed in human PMNs (14). We observed a robust (more than 
100-fold) selective increase in human miR-223 (hsa-miR-223) (Fig. 1B). Confirmatory 
studies demonstrated that this increase occurred in a time-dependent manner in human 
primary alveolar epithelial cells (HPAEpiC) and in the pulmonary epithelial cell line Calu-3 
after coculture with human PMNs (Fig. 1C and fig. S1A). Analysis of baseline amounts of 
hsa-miR-223 in pulmonary epithelia displayed very low expression of miR-223 [cycle 
threshold (Ct) value, 29.14 ± 0.61; culture medium Ct value, 34.52 ± 1.12], whereas PMNs 
demonstrated high expression of hsa-miR-223 (Ct value, 7.95 ± 0.40) (fig. S1B). Also, the 
expression of hsa-miR-223 in HPAEpiC was not inducible by various stimuli tested 
including exposure to N-formyl-Met-Leu-Phe (fMLP) or lipopolysaccharide (LPS) (Fig. 1, 
D and E). In contrast, hsa-miR-223 was found to be about 20-fold lower after coculture of 
PMNs with human microvascular endothelial cell–1 (HMEC-1) (15, 16) than coculture with 
human pulmonary epithelial cells (Calu-3) (fig. S1C). To test whether the hsa-miR-223 
detected in human pulmonary epithelial cells after coculture was functional, we performed 
coculture studies with human pulmonary epithelial cells (Calu-3) that were previously 
transfected with a luciferase reporter carrying a miR-223 target sequence. Significant 
decreases (P < 0.05) in luciferase activity in Calu-3 after coculture indicated that hsa-
miR-223 was functional after coculture (Fig. 1F). To provide additional evidence that 
increases in pulmonary epithelial cell miR-223 after coculture were due to PMNs, we used a 
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murine coculture system that allowed us to study miR-223-deficient PMNs (Fig. 1G). In this 
system, a murine pulmonary epithelial cell line (MLE-12) was cocultured with murine 
PMNs derived from either wild-type or miR-223−/y mice. The miR-223 gene is located on 
the X chromosome; therefore, the knockout mice were hemizygous for miR-223 
(miR-223−/y). The deficiency in miR-223 was confirmed by analyzing miR-223 in murine 
neutrophils from miR-223−/y mice compared to wild-type mouse neutrophils (fig. S1, D and 
E). Analyses of murine miR-223 (mmu-miR-223) after 6 hours of coculture with wild-type 
PMNs revealed a significant increase (P < 0.05), whereas no alteration in epithelial cell 
mmu-miR-223 expression was observed after coculture with murine PMNs derived from 
miR-223−/y mice (Fig. 1H). Moreover, a comparison of miR-223 shuttling in the coculture 
system comprising murine alveolar epithelial cell type I or II (AT-II–like cells, MLE-12 cell 
line; AT-I–like cells, E-10 cell line; Fig. 1I) indicated that miR-223 transfer predominantly 
occurred from neutrophils to AT-II cells. Together, these findings indicate that miR-223 can 
be transferred from PMNs to pulmonary epithelial cells under coculture conditions.
miR-223 release from PMNs is activation-dependent
Next, we examined the supernatant from PMNs for miR-223 content. PMNs released high 
amounts of miR-223 into the supernatant (Fig. 2A). Isolation of microvesicles from the 
supernatant from PMNs via ultracentrifugation showed a high concentration of miR-223 
(Fig. 2B). In addition, incubation of PMN supernatants with HPAEpiC was associated with 
increased miR-223 in HPAEpiC, whereas this response was almost completely abolished 
when using PMN supernatants that lacked the microvesicle fraction (Fig. 2C). Besides the 
secretion of microvesicles, activation of PMNs induced the release of decondensed 
chromatin and granular contents into the extracellular space (17). These structures, called 
neutrophil extracellular traps (NETs), have antimicrobial properties but have also been 
implicated in inflammation. We therefore asked whether the release of NETs (NETosis) was 
involved in the secretion of miR-223 by PMNs. As shown previously, we observed that 
activation of PMNs was associated with increased NETosis (fig. S2A). To address the 
possibility that increased NETosis could also be associated with increased release of 
miR-223, we repeated these studies in the presence of a NETosis inhibitor. Effective 
inhibition of NETosis did not affect miR-223 release, thereby providing evidence that 
NETosis was not a major pathway mediating extracellular miR-223 release (fig. S2, A and 
B). To provide further evidence for PMN-epithelial cell miRNA transfer, we transfected a 
human neutrophil–like cell line (HL-60) with cel-miR-39, a miRNA only present in 
Caenorhabditis elegans, and assessed cel-miR-39 expression in human pulmonary epithelial 
cells (Calu-3) after coculture. We found a robust increase in cel-miR-39 in human 
pulmonary epithelial cells (Calu-3) (fig. S2C). Moreover, the addition of 
monodansylcadaverine (a known inhibitor of clathrin-mediated endocytosis) to the 
supernatant partially attenuated the alveolar epithelial cell uptake of miR-223-containing 
microvesicles, thus implicating clathrin-mediated endocytosis in miR-223 transfer (Fig. 2D). 
Consistent with our work showing PMN transfer of miR-223 into AT-II cells (Fig. 1I), 
previous studies have demonstrated that clathrin-mediated transport is functionally important 
in AT-II cells (18, 19). Together, these findings suggest that miR-223-containing 
microvesicles may be released from PMNs after PMN activation and then could be 
transferred into alveolar epithelial cells.
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PMNs are required for increased pulmonary miR-223 during acute lung inflammation
Given that neutrophils are in close contact with pulmonary epithelial cells during lung 
inflammation, we next examined mmu-miR-223 expression during acute lung inflammation 
in mice. For this purpose, we used a mouse model where lung injury was induced by 
mechanical ventilation [ventilator-induced lung injury (VILI)] (7, 20–22). We found that 
mmu-miR-223 in whole lungs was significantly increased after induction of acute lung 
inflammation in mice (P < 0.05; Fig. 2E). This increase was associated with an increase in 
PMN-derived (CD11b+Ly6G+) microvesicles (fig. S3, A and B). In line with a possible 
transfer of miR-223 from PMNs to alveolar epithelial cells during acute lung inflammation, 
we found that mmu-miR-223 in isolated mouse alveolar epithelial cells was elevated after 
induction of acute lung inflammation (Fig. 2F), whereas miR-223 expression in isolated 
mouse pulmonary endothelial cells remained the same (fig. S3C). To generate mice chimeric 
for miR-223, wild-type mice underwent sublethal radiation and were transplanted with 
miR-223−/y mouse bone marrow and vice versa. Studies of these bone marrow chimeric 
mice revealed that increased mmu-miR-223 in mouse alveolar epithelial cells during 
pulmonary inflammation was predominantly dependent on the presence of mmu-miR-223 in 
bone marrow–derived cells (Fig. 2G and fig. S4, A to C). Similarly, increased mmu-miR-223 
expression during acute lung inflammation was attenuated after antibody depletion of PMNs 
(Fig. 2H and fig. S4, D and E). Although the antibody treatment resulted in significant 
neutrophil depletion, it did not affect monocytes (fig. S4E). Consistent with these findings, 
miR-223 expression was more than 25-fold higher in PMNs than in alveolar macrophages 
(AM ϕ) (fig. S5A), and transfer of miR-223 from bone marrow–derived macrophages 
(BMDM ϕ) to mouse pulmonary epithelial cells was not detectable during coculture (fig. 
S5B). Moreover, induction of miR-223 expression during acute lung inflammation induced 
by mechanical ventilation remained intact after macrophage depletion with clodronate (fig. 
S5C). To study PMN-dependent miRNA release during acute lung injury in mice, we 
examined animals that had been injected with PMN-like cells (HL-60) that had been 
transfected with a synthetic fluorescently labeled miRNA. Intravital microscopy through a 
transthoracic window revealed evidence for release of miRNAs from HL-60 cells that were 
in close proximity to mouse alveolar epithelial cells during acute lung injury induced by 
mechanical ventilation (Fig. 2I). In addition, costaining for AT-II cells (Fig. 2J, green) in 
murine lung tissue sections from ventilated mice that had been injected with labeled PMN-
like cells (HL-60; Fig. 2J, red) suggested that there may also have been transfer of cytoplasm 
from the PMN-like cells in vivo. Moreover, we also observed that patients with ARDS 
(Table 1) showed increased hsa-miR-223 in their bronchoalveolar lavage (BAL) fluid 
compared to healthy control patients (control group mean Ct value for miR-223, 26.61; 
mean Ct value for control ce–miR-39, 23.32; ARDS group mean Ct value for miR-223, 
25.35; mean Ct value for control ce–miR-39, 24.23) (Fig. 2K). Together, these findings 
indicate that PMN-dependent production of mmu-miR-223 contributed to increased 
miR-223 expression in injured mouse lungs after mechanical ventilation and suggest that 
miR-223 was transferred to mouse alveolar epithelial cells during acute lung inflammation.
PARP-1 is a miR-223 target gene in pulmonary epithelial cells
We next performed studies to identify miR-223 target genes in pulmonary epithelial cells. 
For this purpose, we used lentiviral transduction to generate a pulmonary epithelial cell line 
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(Calu-3) that overexpressed miR-223 (Fig. 3, A and B). A whole-genome microarray 
comparing control- transfected Calu-3 cells with Calu-3 miR-223-overexpressing cells 
identified 83 genes with decreased expression in the miR-223-overexpressing cell line (table 
S1). Among genes containing a miR-223 seed match (TargetScan, miRanda, MicroCosm, 
and miRDB), the gene most robustly repressed after miR-223 overexpression was 
poly[adenosine diphosphate (ADP)–ribose] polymerase–1 (PARP-1). PARP-1 is known to 
facilitate inflammatory responses by activating transcription factors such as nuclear factor 
κB (NF-κB) and activator protein–1 (AP-1). PARP-1 drives inflammation-relevant gene 
expression via various proinflammatory cytokines, adhesion molecules, and enzymes 
involved in inflammation. Previous studies demonstrated a detrimental role for PARP-1 
during acute lung injury induced by mechanical ventilation (23). In line with studies from 
the cancer field (24), we confirmed repression of PARP-1 transcripts (Fig. 3C) and protein 
(Fig. 3, D and E) after miR-223 overexpression. We next utilized two luciferase reporter 
plasmids with one containing the wild-type 3′ untranslated region (3′UTR) of PARP-1 and 
the other carrying a mutated version where specific binding of miR-223 to the 3′UTR was 
abrogated (Fig. 3F). Transfection of these plasmids into human pulmonary epithelial cells 
confirmed repression of the wild-type PARP-1 plasmid after miR-223 overexpression, which 
did not occur with the mutated plasmid (Fig. 3, G and H). A coculture system comprising 
human PMNs and human pulmonary epithelial cells (Calu-3) (Fig. 1A) revealed repression 
of PARP-1 transcripts in the pulmonary epithelial cells (Fig. 3I). Together, these findings 
identify PARP-1 as a miR-223 target gene.
miR-223–/y mice develop severe lung inflammation during acute lung injury
To address the functional role of miR-223 during pulmonary inflammation, we next 
performed genetic studies in miR-223–/y mice (25). We induced acute lung injury using 
mechanical ventilation in miR-223–/y mice or wild-type control mice matched for age, 
gender, and weight Consistent with a functional role for miR-223 in repressing 
inflammatory gene expression, we found that, compared to control mice, miR-223–/y mice 
showed increased permeability of lung alveolar cells (Fig. 4A). The miR-223–/y mice also 
showed greater lung inflammation as assessed by measurement of bronchoalveolar 
myeloperoxidase (Fig. 4B), bronchoalveolar cytokines (Fig. 4, C and D), histological tissue 
injury (Fig. 4, E and F), and lung wet- to-dry weight ratios (fig. S6A). The repression of 
PARP-1 protein during VILI seen in wild-type mice was attenuated in miR-223-deficient 
mice (Fig. 4, G and H). In addition, analysis of PARP-1 enzyme activity revealed increased 
PARP-1 activity in miR-223–/y animals (Fig. 4, I and J). Moreover, miR-223-deficient mice 
also experienced increased tissue inflammation during pulmonary infection with methicillin-
resistant Staphylococcus aureus (strain USA300). At early time points (4 hours after 
infection), miR-223–/y mice showed increased permeability of alveoli to proteins, elevated 
myeloperoxidase in the BAL, and augmented inflammatory cytokine production in 
pulmonary tissue (Fig. 5, A to G). In addition, mice lacking mmu-miR-223 showed 
significantly reduced survival during acute lung inflammation induced by S. aureus infection 
compared to wild-type mice (P < 0.05; Fig. 5H). Analysis of bacterial clearance revealed no 
significant difference between wild-type and miR-223–/y mice (Fig. 5, I and J), indicating 
that reduced survival in mice lacking mmu-miR-223 was unlikely to be due to reduced 
bacterial killing.
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To demonstrate that increased lung inflammation and more severe acute lung injury in 
miR-223–/y mice were related to the miR-223 target gene PARP-1, we attempted to reverse 
the phenotype of miR-223–/y mice by repressing PARP-1 genetically using lentiviral 
transduction with a short hairpin RNA (shRNA) vector that was specific for PARP-1. 
Intratracheal administration of lentiviral shRNA was associated with reduced PARP-1 
protein and PARP-1 enzyme activity at baseline and after VILI (Fig. 6, A to D). Functional 
studies analyzing the outcome after induction of VILI demonstrated that lentiviral shRNA-
mediated PARP-1 repression in miR-223–/y mice was associated with a reversal of the lung 
inflammation phenotype (Fig. 6, E to K). Measurements of the alveolar epithelial injury 
markers RAGE (receptor for advanced glycation end-products) and the alveolar cell protein 
T1α revealed lower concentrations of both molecules in miR-223–/y mice with shRNA-
mediated PARP-1 repression (fig. S7, A and B). In addition, these mice also showed lower 
numbers of TUNEL (terminal deoxynucleotidyl transferase-mediated deoxyuridine 
triphosphate nick end labeling)-positive cells, implying a reduced cell death rate after 
PARP-1 repression (fig. S7C).
Collectively, these studies demonstrate that genetic deletion of miR-223 promoted increased 
lung injury during acute pulmonary inflammation induced by mechanical ventilation or 
bacterial infection. In addition, pulmonary edema and lung inflammation in miR-223–/y 
mice were reduced by overexpression of mmu-miR-223 and repression of PARP-1.
Inducing pulmonary miR-223 overexpression with nanoparticles dampens acute lung 
inflammation
We next pursued the possibility that overexpression of miR-223 was associated with lung 
protection during acute lung injury induced by mechanical ventilation. For this purpose, we 
treated wild-type mice endotracheally with nanoparticles containing synthetic miR-223 
mimics (26). This treatment was associated with robust repression of PARP- 1 transcripts in 
mouse alveolar epithelial cells (Fig. 7A). Previous studies using a PARP-1 inhibitor (PJ34) 
revealed that PARP-1 repression was beneficial during pulmonary inflammation, suggesting 
that miR-223-elicited PARP-1 repression could be useful for treating acute lung injury (23). 
Functional studies of lung inflammation induced by mechanical ventilation demonstrated 
that pulmonary overexpression of miR-223 in mouse lungs was associated with decreased 
albumin detection in the BAL fluid (Fig. 7B) and attenuated lung wet-to-dry weight ratios, 
indicating improved alveolar-capillary barrier function (Fig. 7C). Pulmonary overexpression 
of miR-223 was also associated with attenuated lung inflammation (Fig. 7, D to J). To 
address the effects of miR-223 overexpression in an infectious disease model of acute lung 
injury, we exposed mice intratracheally to methicillin-resistant S. aureus (strain USA300). 
Pulmonary overexpression of miR-223 attenuated lung edema, inflammation, and tissue 
injury during pulmonary infection with S. aureus (Fig. 8, A to G). Moreover, pulmonary 
miR-223 overexpression provided significantly improved mouse survival during acute lung 
inflammation induced by pulmonary S. aureus infection compared to mice treated with a 
control vector (P < 0.05, Mantel-Cox test; Fig. 8H). Analysis of pulmonary bacterial 
clearance revealed no difference between miR-223-overexpressing mice and control animals 
(Fig. 8, I and J). Pulmonary overexpression of miR-223 was associated with reduced 
PARP-1 protein expression (fig. S8, A and B) and a reduction in epithelial cell injury as 
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measured by lowered T1α protein and reduced cell death (analyzed by TUNEL staining) 
(fig. S8, C and D).
Together, these data provide evidence that overexpression of miR-223 was associated with 
protection from lung inflammation and pulmonary edema during acute lung injury induced 
by mechanical ventilation or pulmonary S. aureus infection.
DISCUSSION
Here, we pursued the hypothesis that during acute lung injury, miRNAs are shuttled from 
PMNs to pulmonary epithelial cells, thereby providing a feedback mechanism to dampen 
inflammatory gene expression and lung inflammation. An experiment where human PMNs 
were coincubated with HPAEpiC revealed a selective increase in miR-223 expression by 
alveolar lung epithelial cells. Basal expression of miR-223 in HPAEpiC was very low, and 
external stimulation with LPS or fMLP failed to induce endogenous up-regulation of 
miR-223. Genetic studies using a coculture system comprising PMNs derived from 
miR-223−/y mice demonstrated that this increase in miR-223 reflected transfer of miR-223 
from PMNs to the pulmonary epithelial cells. Moreover, further studies demonstrated that 
the release of miR-223 into the supernatant was increased upon activation of the PMNs and 
that transfer of miR-223 into alveolar epithelial cells was mediated by microvesicles. Studies 
of miR-223 target genes in human pulmonary epithelial cells indicated that anti-
inflammatory functions of miR-223 during acute lung injury involved the miR-223 target 
gene PARP-1. Functional studies demonstrated that miR-223−/y mice were prone to acute 
lung inflammation induced by mechanical ventilation and that endotracheal application of 
miR-223-containing nanoparticles reversed this phenotype. Treatment with miR-223-
containing nanoparticles provided protection from lung inflammation and pulmonary edema 
in wild-type mice during acute lung injury induced by mechanical ventilation or pulmonary 
infection with S. aureus. Together, these findings implicate PMN-dependent miR-223 
transfer in an endogenous feedback mechanism that may limit excessive lung inflammation 
during acute lung injury via repression of PARP-1 (Figs. 7 and 8).
Previous studies have implicated miR-223 in PMN development and function. Human 
granulocytic differentiation is controlled by a regulatory circuitry involving miR-223, 
indicating that miR-223 may play a crucial role during granulopoiesis (27, 28). Other studies 
suggest that miR-223 expression might be driven by myeloid transcription factors (29). 
Meanwhile, studies using a loss-of-function allele in mice show that miR-223 negatively 
regulates myeloid progenitor cell proliferation and granulocyte differentiation and activation. 
In those initial studies, stimulation of mouse wild-type and miR-223−/y neutrophils with 
different concentrations of phorbol 12-myristate 13-acetate (PMA) led to production of 
lower amounts of reactive oxygen metabolites. Additionally, the observed percentage of 
wild-type versus miR-223−/y PMNs that underwent a respiratory burst was much lower. On 
the basis of those initial studies generating and characterizing the miR-223−/y mouse 
phenotype, the lack of miR-223 in the mutant mouse neutrophils induced a hypersensitive 
state in response to activating stimuli (25). As a consequence of this neutrophil 
hyperactivity, miR-223−/y mice spontaneously develop inflammatory lung pathology and 
exhibit exaggerated tissue destruction after endotoxin challenge (25). Our study indicates 
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that miR-223 dampens lung injury induced by mechanical ventilation or by pulmonary 
infection with S. aureus.
We identified PARP-1 as a target gene of miR-223 in pulmonary epithelia. PARP-1 is a 
member of the PARP family, which is composed of enzymes that catalyze a posttranslational 
modification called poly (ADP-ribosyl)ation (30). PARP-1 is expressed in all mammalian 
cells except mature granulocytes, which is in line with our findings that miR-223-dependent 
lung protection involves the transfer of miR-223 to another cell type. PARP-1 is involved in 
the regulation of various biological activities, including DNA repair, DNA replication, 
transcription, and proteasomal degradation. However, PARP-1 has also been implicated in 
inflammation and in ischemia-reperfusion tissue injury (30–32). Consequently, 
pharmacological inhibition or genetic deletion of PARP-1 has been shown to protect against 
inflammatory diseases, such as acute lung injury. Our findings of miR-223-dependent 
PARP-1 repression during acute lung injury are in line with an anti-inflammatory role for 
miR-223 shuttled by PMNs during pulmonary inflammation (31). Our observations in 
miR-223−/y mice using PARP-1 shRNA to inhibit PARP-1 expression during pulmonary 
inflammation are consistent with previous studies where PARP-1 inhibitors decreased lung 
permeability in lung injury mouse models (31). The improved barrier function we observed 
during induction of lung inflammation by mechanical ventilation in miR-223−/y mice with 
shRNA-mediated PARP-1 inhibition, indicated by reduced albumin leakage and diminished 
lung edema, is in agreement with observations in other inflammatory diseases. For example, 
pharmacological PARP-1 inhibition resulted in a reduction in proinflammatory cytokine 
production and in intestinal permeability in a murine model of experimental colitis (33). 
Similarly, our observations of diminished lung epithelial cell inflammation after transfer of 
miR-223 from neutrophils to alveolar epithelial cells indicate an anti-inflammatory and 
protective role for miR-223-mediated PARP-1 inhibition during acute lung injury.
Studies from the cancer field indicate that miRNAs can be released from microvesicles 
produced by cancer cells and implicate miRNA transfer in tumor expansion and metastasis. 
Our study suggests that inflammatory cells, such as PMNs, may release miRNAs in 
microvesicles to provide anti-inflammatory signals to pulmonary epithelial cells. Previous 
studies have shown that neutrophils can release anti-inflammatory microvesicles upon 
activation (34, 35). Lung infiltration by activated PMNs has been implicated as a key event 
in the development of lung inflammation during acute lung injury. The release of miR-223–
containing microvesicles by PMNs may be a signal for the resolution of epithelial 
inflammation. Our findings suggest that neutrophils, often thought to only accelerate 
inflammation and injury, may play a critical role in injury repair potentially by transferring 
miR-223 to lung alveolar epithelial cells. These findings are consistent with previous studies 
implicating neutrophils in epithelial repair of the injured lung (36). Although they are crucial 
for fighting infection, neutrophils could also contribute to lung injury through several 
mechanisms that cause collateral damage (37). For VILI, neutrophil infiltration is a key 
event (38). High-pressure ventilation-induced pulmonary inflammation results in damage to 
the alveolar-capillary barrier, as shown in our study by increased albumin in the BAL fluid. 
During VILI, there is an increase in myeloperoxidase produced by neutrophils, indicating a 
PMN influx into the lungs. Exaggerated neutrophil activation and the release of microbicidal 
compounds and proinflammatory cytokines into the extracellular space can damage host 
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tissues. Several studies have shown that depletion of granulocytes during lung injury 
attenuates inflammation and reduces the severity of lung injury (39, 40). In contrast, in other 
inflammatory disease models, there is also evidence that neutrophil depletion can aggravate 
inflammatory disease progression (41). Our study suggests that the infiltrating neutrophils 
provide an additional protective mechanism through transfer of miR-223 to the lung 
epithelium.
The phenomenon of neutrophil-epithelial cross-talk highlighted here was found to occur in 
different types of pulmonary epithelial cells. This is in line with previous observations that 
PMNs can migrate across connective tissue and epithelial barriers throughout the respiratory 
tract. We found some indication that miR-223 transfer primarily involves AT-II cells of the 
lung alveoli. AT-II cells have been described as relatively resistant to cell death during acute 
tissue injury, and miR-223-mediated AT-II cell protection may play a functional role during 
the acute phase of lung injury and repair.
Although our data suggest a functional role for miR-223–dependent miRNA transfer during 
acute lung injury, there are a number of major limitations to our study. Although we 
observed a protective role for miR-223 in the acute phase of lung injury and lung infection, 
the functional role of miR-223 during chronic states of lung disease and the impact on lung 
injury resolution remain unknown. Much of our study was carried out in miR-223−/y mice 
with global deletion of miR-223; additional studies in mice with miR-223 deletion in 
different lung tissue compartments may have the potential to identify additional miR-223 
functions and other target genes. We identified PARP-1 as an epithelial miR-223 target gene 
mediating the protective role of miR-223 during acute lung injury. Given that miRNAs 
usually regulate multiple target genes, it is likely that there are miR-223 gene targets in 
addition to PARP-1 that could be involved in protection against pulmonary inflammation. 
We only examined global miR-223 expression in BAL fluid from patients with ARDS, but 
future studies will need to examine miR-223 expression in subgroups of patients suffering 
from lung injury and at diverse stages of disease.
MATERIALS AND METHODS
Study design
We combined several approaches to investigate miRNA transfer from neutrophils to alveolar 
epithelial cells during acute lung injury in mice. First, we established a coculture system in 
vitro using PMNs and pulmonary epithelial cells of human or murine origin to study miRNA 
transfer. Two different murine models of acute lung injury were used to investigate the 
transfer of miR-223 during pulmonary inflammation: a mechanical VILI model and a 
bacterial infection model of acute murine pneumonia. For histology scoring, the researcher 
was blinded to the treatment group and sample identity. Numbers of replicates for 
experiments are specified in the corresponding figure legends. Two different genotypes of 
mice were used to confirm the critical role of miR-223: wild-type and miR-223−/y mice. To 
further explore the relevant myeloid cell type as a source of miR-223, bone marrow chimeric 
mice were generated, and depletion studies were conducted. For miR-223 target 
identification, microarray analysis and ludferase assays were used. As proof of principle, 
miR-223 was overexpressed using nanopartide-packaged miR-223 mimics. Analysis of 
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miR-223 in human samples was performed on BAL fluid collected from 55 patients with 
ARDS within the first 7 days after diagnosis. Demographic and clinical data such as 
APACHE II scores and primary etiology are shown in Table 1. BAL fluid samples derived 
from healthy individuals served as controls. All eight control subjects were between 18 and 
55 years of age, were not taking any medications, and were lifelong nonsmokers. There were 
five males and three females.
Cell culture and treatments
Primary alveolar epithelial cells (HPAEpiC, ScienCell Research Laboratories), human 
airway epithelial cells [Calu-3, American Type Culture Collection (ATCC)], murine alveolar 
epithelial cells (MLE-12, gift from I. Douglas, Pulmonary Sdences and Critical Care 
Medicine, School of Medicine University of Colorado, USA; E-10, gift from D. C. 
Thompson, Department of Clinical Pharmacy, School of Pharmacy University of Colorado, 
USA), and human promyelocytic leukemia cells (HL-60, ATCC) were cultured according to 
the manufacturer’s instructions and in the appropriate media. During coculture, all cell types 
were incubated in Hanks’ buffer.
Coculture experiments
Coculture experiments were set up using Transwell plates with 0.4-μm pore size 
polycarbonate membrane inserts (Coming) according to the manufacturer’s instructions. 
Depending on the readout, cocultures were carried out in 6-, 12-, or 24-well inserts. 
Pulmonary epithelial cells (Calu-3, HPAEpiC, MLE-12, and E-10) were seeded and grown 
to confluence in the lower chamber before coculture. During coculture, appropriate numbers 
[a ratio of 1:2 for all experiments, except Fig. 1E (ratio, 1:3)] of either freshly isolated 
human PMNs (activated with fMLP), murine isolated PMNs [activated with PMA (0.1 μg/
ml)], or neutrophillike HL-60 cells [differentiated 4 days with dimethyl sulfoxide (DMSO)] 
were added to the upper chamber, and coculture was carried out for 4 to 6 hours. Under 
control conditions, epithelial cells were treated with fMLP (1 mM) or LPS (10 μg/ml) for 6 
hours. At the end of each coculture experiment, PMN-containing inserts were removed, and 
cells in the lower chamber were washed once with 1× phosphate-buffered saline (PBS), 
followed by an immediate lysis with QIAzol for RNA analysis. In the case of coculture 
experiments, luciferase-transfected pulmonary epithelial cells were transfected 24 hours 
before coculture, inserts were removed after 6 hours of coculture, and transfected cells in the 
lower chamber were further cultured for another 48 hours before lysis and ludferase activity 
measurements. In studies analyzing the epithelial microveside uptake mechanism, human 
pulmonary alveolar epithelial cells (HPAEpiC) were pretreated with 50 μM 
monodansylcadaverine (MDC; Sigma-Aldrich), an inhibitor of dathrin-dependent 
endocytosis (42), 30 min before coculture.
Generation of overexpressing miR-223 cell line
Green fluorescent protein (GFP)-miR-223 precursor construct, built in a lentiviral vector 
backbone (purchased from SBI), was produced by cotransfecting the plasmid with pPACK 
packaging mix (SBI into 293T cells, ATCC) to generate lentiviral partides. Virus-containing 
supernatants were harvested according to the manufacturer’s instructions (SBI), and Calu-3 
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were transduced with either GFP-miR-223 lentivirus or GFP-control lentivirus according to 
the manufacturer’s instructions.
Binding of miR-223 to miR-223 target vector or 3′UTR of PARP-1
Cells (Calu-3 or lentiviral-transduced Calu-lenti-223 or Calu-lenti-ctr) were transfeded with 
PARP-1 3′UTR reporter construct (ludferase vedor containing the 3′UTR of PARP-1 
downstream the ludferase gene; OriGene) or miR-223 target vedor (vedor containing a target 
sequence for miR-223 downstream the ludferase gene; SwitchGear) or with respective 
control vedors. Forty-eight hours later, cells were harvested, and ludferase activity was 
measured using the Dual-Luciferase Reporter kit (Promega) (for the PARP-1 3′UTR 
reporter construd) or the LightSwitch Ludferase Assay Kit (SwitchGear) (for the miR-223 
target vedor) according to the manufacturer’s instructions.
Isolation of human PMNs
The collection and use of human PMNs from healthy volunteers were approved by the 
Colorado Multiple Institutional Review Board (COMIRB), and before each blood draw, 
written informed consent from each individual was obtained. For isolation of human PMNs, 
human blood was obtained by venipuncture from healthy volunteers. The blood was 
anticoagulated with an ACD (add-citrate-dextrose) buffer and added to 3% dextran solution 
for sedimentation. To separate cells, we carefully layered anticoagulated whole blood on top 
of a density gradient cell separation medium of Ficoll and sodium diatrizoate 
(Histopaque-1077, Sigma-Aldrich). After centrifugation at 2700 rpm for 30 min at room 
temperature without break, supernatant was removed, PMNs containing pellet (from this 
step onward, all steps were carried out at 4°C) were resuspended, and residual erythrocytes 
were removed with two washes of ice-cold RCLB (red cell lysis buffer) and then washed 
twice in Hanks’ buffer (−). During counting and until experiments were started, PMNs were 
kept in Hanks’ buffer (−) and at 4°C. For activation, PMNs were transferred from Hanks’ 
buffer (−) to Hanks’ buffer (+) supplemented with 1 pM/MLP and incubated at 37°C. The 
viability of the cells after isolation was greater than 97% using the trypan blue dye exclusion 
test.
Isolation and purification of murine PMNs
Murine PMNs were isolated from the bone marrow of C5BL/6 or miR-223−/y mice using the 
EasySep Mouse Neutrophil Enrichment Kit (STEMCELL Technologies) according to the 
manufacturer’s instructions. The negative selection method was chosen because it is 
considered to result in less activation (compared to positive selection methods) during the 
purification procedure. Briefly, mice were euthanized, and the bone marrow was harvested 
from femurs and tibias. Cells were centrifuged and incubated with a cocktail of biotinylated 
antibodies for negative selection, again centrifuged and then incubated with EasySep D 
magnetic particles. Subsequently, cells were placed in an EasySep Magnet to separate and 
finally decant the nonlabeled purified murine PMNs. All steps were carried out at 4°C to 
avoid any activation of cells before starting the desired experiment.
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Isolation of murine AMϕ
Murine AMϕ were isolated as previously described (43).
Isolation of pulmonary endothelial cells
Murine pulmonary endothelial cells were isolated as previously described (44).
Lung injury score
Murine lung histology was scored blinded according to lung injury scoring criteria published 
previously (45).
Isolation and culture of murine BMDMϕ
Murine BMDMϕ were isolated and activated as previously described (46).
Microvesicle isolation from PMN supernatant/human BAL samples
PMN-derived microvesicles were isolated by sequential ultracentrifugation as described 
previously (34). Briefly, after culture of freshly isolated PMNs, supernatants were collected, 
and cell debris was removed by two consecutive centrifugations (4000g for 20 min at 4°C). 
Then, to collect the PMN-derived microvesides, the supernatants were ultracentrifuged at 
160,000g for 60 min at 4°C in a Type 70.1 Ti rotor (Beckman Instruments Inc.). The pelleted 
microvesicles were further processed depending on the experimental setup; either the 
pelleted microvesicles were directly lysed in QIAzol for RNA isolation using the RNeasy kit 
(Qiagen) following the manufacturer’s instructions provided or kept in PBS for other 
experiments.
Microvesicle analysis with flow cytometry
Microvesides were obtained from murine lungs by performing BAL with PBS that had been 
filtered through a 0.2-μm filter to remove particulate debris. Lavage fluid was then 
centrifuged at 200g for 5 min to pellet cells. One hundred microliters of cell-free supernatant 
was removed and incubated on ice for 30 min with fluorescently conjugated antibodies 
directed against CD45 (clone 30-F11, BD Biosciences) and CD11b (clone M1/70, BD 
Biosdences) at concentrations of 1:100. Control isotype antibodies were added to paired 
aliquots at similar concentrations. Samples were diluted with 900 μl of filtered PBS and 
taken to flow cytometry where calibrated fluorescent microveside sizing beads (Megamix, 
Biocytex) were added at a concentration of 27,000/ml. Microvesides from cultured human 
neutrophils were analyzed by adding antibodies directed against CD45 (clone TU116, BD 
Biosdences) and CD11b (clone ICRF44, BD Biosciences) to 100 μl of cell culture 
supernatant for 30 min. Specimens were diluted in 900 pi of filtered PBS, and Megamix 
beads were added. Flow cytometry for all experiments was performed on a Gallios 561 
cytometer (Beckman Coulter) with a wide-angle forward scatter aperture. Forward and side 
scatter thresholds were set using calibrated microbeads. Microvesides were enumerated by 
collecting events between 0.2 and 0.9 μm in size after excluding microbeads based on their 
fluorescence.
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Quantification of NET release from activated neutrophils
NETs were quantified using fluorimetry as described previously (47). Briefly, freshly 
isolated neutrophils were cultured in 96-well microtiter plates and stimulated with fMLP at a 
concentration of 1 μM. For inhibition of secretion of NETs, PMNs were pretreated with 
NETosis inhibitor Cl-Amidine (1 mM for 15 min) (Cayman Chemical). SYTOX Green, a 
non–cell-permeant DNA binding dye (Thermo Fisher), was added to the cells at 5 μM 
concentration to detect extracellular DNA. The degree of the fluorescence of treated cells 
was obtained after subtracting baseline fluorescence of medium only, and the data were 
normalized as 100% NET formation to the stimulus, leading to the greatest degree of 
NETosis (stimulation with jMLP) to more readily assess the fold reduction. The plates were 
read in a fluorescence microplate reader with a filter setting of 485 nm (excitation)/525 nm 
(emission).
Patient samples
Collection and use of patient samples were approved by the appropriate institutional review 
board (IRB) of each institution, and COMIRB approval had been obtained. BAL fluid was 
collected from 55 patients with ARDS within the first 7 days after diagnosis. Demographic 
and clinical data APACHE II scores and primary etiology are shown in Table 1. BAL fluid 
samples derived from healthy individuals served as controls. All eight control subjects were 
between 18 and 55 years of age, were not taking any medications, and were lifelong 
nonsmokers. There were five males and three females.
Mice
Experimental protocols were approved by the IRB at the University of Colorado Denver, 
CO. They were in accordance with the protection of animals and the National Institutes of 
Health guidelines for use of live animals. miR-223−/y mice were a gift from V. Dawson 
(Johns Hopkins University School of Medicine, Baltimore, MD), and wild-type C57BL/6J 
mice were obtained from the Jackson Laboratory. The miR-223−/y mice were generated on a 
C57BL/6 background. We had received mating pairs of miR-223 knockout mice on the 
background of C57BL/6 (male, miR-223−/y; female, miR-223−/−) and wild-type C57BL/6 
mice. Both miR-223 knockout mice and the C57BL/6 mice that served for wild-type control 
mice have been bred and held in the same specific pathogen-free barrier unit For 
experiments, miR-223−/y and wild-type mice have been matched for age and gender 
accordingly.
Mouse strains
miR-223−/y mice were generated and first characterized in 2008 (25). The miR-223 locus is 
located on the X chromosome and is transcribed independently of any known genes. The 
miR-223−/y mice were generated on a C57BL/6 background. These mice are fertile, were 
bom at normal Mendelian ratios, and do not show any gross abnormalities when maintained 
in a pathogen-free environment. At the age of 8 to 10 weeks, these mice do not display any 
pulmonary abnormalities. We received mating pairs of miR-223 knockout mice on a 
C57BL/6 background (male, miR-223−/y; female, miR-223−/− and wild-type C57BL/6 
mice). Both miR-223 knockout mice and the C57BL/6 mice that served for wild-type control 
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mice have been bred and held in the same specific pathogen-free barrier unit. For 
experiments, miR-223−/y and wild-type mice have been matched for age and gender 
accordingly.
Murine model for VILI
Murine model for in situ acute VILI was performed as described before (7,20–22). Briefly, 
acute lung injury was induced with 3 hours of pressure- controlled ventilation using high 
inspiratory pressure of 45 mbar (2- to 5-mbar positive end-expiratory pressure). For that 
purpose, animals were anesthetized with pentobarbital [70 mg/kg intraperitoneally (ip) for 
induction and 20 mg/kg per hour for maintenance] and maintained at stable body 
temperature using a thermal feedback controller (heating tables and rectal thermometer 
probes), and fluid was replaced with normal saline (0.05 ml/hour ip). After tracheotomy, a 
tracheal tube was connected to a mechanical ventilator (Siemens Servo 900C, with pediatric 
tubing). For all experiments, mice were ventilated in a pressure- controlled ventilation mode 
with 100% inspired oxygen.
Pulmonary bacterial infection
For S. aureus experiments, bacteria were grown, as described previously, and administered 
by 50 μl of intratracheal inocula at 2 × 108 to 5 × 108 colony-forming units per animal (48). 
S. aureus strains were grown at 37°C to mid-exponential phase OD600 (optical density at 600 
nm) = 1 (~3 hours) in CCY medium [3% yeast extract, 2% Bacto Casamino adds, 2.3% 
sodium pyruvate, 0.63% Na2HPO4, and 0.041% KH2PO4 (pH 6.7)].
Bone marrow chimera
To address the miR-223 transfer during VILI in vivo, bone marrow mouse chimeras were 
generated as described previously (7, 49), in which bone marrow was ablated by radiation in 
wild-type C57BL/6J mice followed by reconstitution with bone marrow derived from 
miR-223−/y (gene-targeted for miR-223) and vice versa (miR-223−/y→wild type and wild 
type→miR-223−/y; fig. S4A). Briefly, bone marrow cells harvested from femurs and tibias 
of euthanized male mice at 8 to 10 weeks of age were transplanted into irradiated (total dose 
of 2 × 6 gray) recipient mice immediately after irradiation. To monitor transplantation 
efficiencies, parallel experiments using the same regimen were carried out transplanting 
CD45.2 bone marrow into irradiated CD45.1 mice, and chimerism was examined by flow 
cytometric analysis at 6 to 8 weeks after irradiation, correlating with the time of induction of 
VILI in the experimental chimeric mice (fig. S4B). For this purpose, blood was taken from 
transplanted recipients; red blood cells were lysed, centrifuged, and resuspended in 200 μl of 
PBS containing 1% bovine serum albumin (BSA) to determine the percentage of neutrophils 
expressing CD45.2 in these chimeras (CD45.2→CD45.1); cells were incubated with anti-
mouse-CD45.1 antibody (done A20, BioLegend), anti-mouse- CD45.2 antibody (clone 104, 
eBioscience), anti-mouse-major histocompatibility complex II antibody (clone M5/114.15.2, 
eBioscience), and anti-mouse-Ly6G antibody (done 1A8, BD Biosciences), and analysis was 
carried out.
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PMN depletion
To deplete neutrophils 24 hours before induction of VILI, mice were given a single dose (1 
mg, ip) of Ly6G-specific antibody (1A8, BioXcdl). Control stands for no antibody treatment. 
These mice received equal volumes of vehide (PBS) at the same time point as the 
experimental mice received the antibody dose. Flow cytometric analysis demonstrated that 
depletion was successful (fig. S4, D and E).
Monocyte and macrophage depletion
To deplete monocytes and macrophages 24 hours before induction of VILI, mice were given 
a combined dose of 100 μl of clodronate liposomes intratracheally plus 200 μl intravenously 
(ClodronateLiposomes.com). Control mice received equal amounts of control liposomes 
without dodronate at the same time points.
Closed-chest pulmonary intravital microscopy
Intravital microscopy of the subpleural microvasculature of male wildtype mice was 
performed as previously described (50). The dye-labeled mimic was purchased from 
Dharmacon (miRIDIAN Mimic) and was labded with Dy547, a dye with absorbance and 
emission maximum at 557 and 570 nm, respectively. The mimic-transfected and Calcein-
stained HL-60 cells (9 × 106 cells in 200 μl of PBS) were injeded intravenously. After 
injection and intravital microscopy surgical preparation, mice were ventilated with high tidal 
volumes. High tidal volume ventilation was continued while performing confocal intravital 
microscopy using a Nikon AIR microscope with a CFI 75 Apo long working distance 25× 
objective (numerical aperture, 1.1).
Labeling, intravenous injection of PMN-like cells (HL-60), and visualization by costaining
Neutrophil-like differentiated (4 days with DMSO treatment) HL-60 cells were labded using 
the Qtracker 655 Labeling Kit (Life Technologies) following the manufacturer’s 
instructions. Thirty minutes before ventilation and induction of acute lung injury, 10 million 
labded cells were injected retro-orbitally in a total volume of 100 μl per mouse. After 
induction of VILI, lungs were harvested and paraffin-embedded, and AT-II cells were 
stained with FITC-pro-SPC. Costaining was analyzed by fluorescence microscopy.
Nanoparticle treatment
To obtain pulmonary overexpression of miR-223, we used a nanopartide- based approach to 
transport synthetic mmu-miR-223 into the alveolar space. Neutral lipid emulsion (NLE) 
consists of 1,2-dioleoyl-sn-glycero- 3-phosphocholine, squalene oil, polysorbate 20, and an 
antioxidant that, in complex with synthetic miRNAs, form nanopartides in the nanometer 
diameter range (26). Mice were twice (96 and 48 hours before VILI) given a dose of 20 μg 
of synthetic mmu-miR-223 (mimic-223; Dharmacon) or respective control mimic (mimic-
ctr) formulated with NLE according to the manufacturer’s instructions (MaxSuppressor In 
Vivo RNA-LANCEr II, Bioo Scientific) by intratracheal injection.
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In vivo PARP-1 inhibition
For genetic knockdown of PARP-1 in vivo, 50 μl of saline-formulated high-titer lentiviral 
shRNA specifically inhibiting PARP-1 (formulated high-titer lentiviral shRNA specifically 
inhibiting PARP-1, “PARP-1 shRNA”; Sigma-Aldrich) or control lentivirus (empty vector 
control plasmid DNA that contains no shRNA insert; MISSION pLKO.1-puro Empty Vector 
Control Plasmid DNA; Sigma-Aldrich) was administered 72 hours before VILI into male 
miR-223 knockout mice by an intratracheal injection.
BAL and lung tissue harvest
Mice were euthanized after 3 hours of ventilation or no ventilation (control), and lungs were 
lavaged with 1 ml of sterile PBS (for protein analysis, etc.). After lavage, lungs were 
perfused with 10 ml of ice-cold saline via the right ventricle to remove any remaining blood 
in the pulmonary circulation. Lungs were excised and, together with the BAL fluid samples, 
immediately snap-frozen and stored at −80°C until further processed.
Lung wet-to-dry weight ratio
The lung wet weight-to-dry weight ratios have been performed as described previously.
Microscopic image acquisition
All standard histological images displayed were captured using an Olympus BX51 system 
microscope supplemented with an Olympus DP72 microscopic digital camera. Images were 
taken at room temperature using an UPIanApo 10×/0.40 objective lens providing ×100 
magnification. For aquisition, cellSens Dimension (version 1.41) from Olympus was used.
Transcriptional analysis
Total RNA or separated fractions of mRNA and miRNA were isolated from human epithelial 
cells, murine lung tissue, or murine AT-II cells using QIAzol reagent and RNeasy kit 
following the manufacturer’s instructions (Qiagen). Transcript levels were determined by 
real-time RT-PCR using specific primer sets (Qiagen). For normalization of expression 
levels, endogenous expression levels of RNU-6 or SNORD48 or spiked-in cel-miR-39 were 
used for miRNA studies, and endogenous expression levels of β-actin were used for 
normalization of all the cytokines (IL-6, IL-1β, CXCL-1, and TNFα), as well as for PARP-1 
expression levels.
Isolation of murine alveolar epithelial cells
AT-II cells were purified as described previously (51). Briefly, after induction of VILI, mice 
were euthanized by pentobarbital overdose. Lungs were lavaged with 3 × 1 ml of sterile PBS 
and then perfused with ice-cold saline via the right ventricle. As previously described, 3 ml 
of prewarmed dispase (BD) was instilled, followed by 0.5 ml of a low-melting point agarose, 
and chest cavity was iced for 2 min to harden the agarose plug. Lungs were removed intact 
and incubated in 1 ml of dispase at 37°C for 15 min. Tissue was dissociated manually, and 
cells were filtered (70/40 μm; Thermo Fisher), followed by centrifugation. Pelleted cells 
were resuspended and labeled with CD45 MicroBeads (Miltenyi Biotec), followed by 
negative selection using magnetic sorting technology. CD45-negative cells were next treated 
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with Fc receptor-blocking monoclonal antibody (eBioscience) and labeled with anti-
epithelial cell adhesion molecule (EpCAM) biotin (eBioscience) and anti-biotin DyLight 
633. EpCAM-positive cells were positively selected using streptavidin magnetic microbeads 
(Miltenyi). Successful purification of AT-II cells was confirmed by analyzing cells for 
EpCAM expression using flow cytometric analysis (fig. S4C).
Bronchoalveolar lavage
To obtain BAL fluid after 3 hours of ventilation or from control mice, the tracheal tube was 
disconnected from the mechanical ventilator, and the lungs were lavaged with 1.0 ml of 
PBS. All removed fluid was immediately snap-frozen and stored at −80°C for later 
measurement of the albumin concentration or myeloperoxidase content.
ELISA (albumin, myeloperoxidase, and cytokines) in BAL fluid
BAL fluid samples were thawed to 4°C, and specific protein concentrations in BAL fluid 
were determined using specific ELISA kits according to the instructions given by the 
manufacturer: myeloperoxidase (Hycult Biotech) and albumin (Bethyl Laboratories).
Immunoblotting experiments
For detection of PARP-1 protein in cell lysates or murine lung tissue, mouse polyclonal 
PARP-1 antibodies (C2-10 and B-10; Santa Cruz Biotechnology) were used. For protein 
loading control, stripped blots were reprobed for β-actin using a mouse monoclonal anti-
human β-actin primary antibody (CP01, Calbiochem). Briefly, cell lysate or murine lung 
tissue-derived protein samples were solubilized in reducing Laemmli sample buffer and 
heated to 90°C for 5 min. Samples were resolved on a 10% polyacrylamide gel and 
transferred to nitrocellulose membranes (Trans-Blot Turbo, Bio-Rad). The membranes were 
blocked for 40 min at room temperature in tris-buffered saline-Tween 20 (TBS-T) 
supplemented with 2% BSA. The membranes were incubated in 1:1000 mouse polyclonal 
PARP-1-antibody at 4°C overnight, followed by three 10-min washes in TBS-T. 
Subsequently, membranes were incubated in 1:5000 goat anti-mouse horseradish peroxidase 
(ImmunoPure Antibody, Thermo Scientific). After another series of three 10-min washes in 
TBS-T, proteins were detected by enhanced chemiluminescence (SuperSignal West Femto 
Maximum Sensitivity Substrate, Thermo Scientific). Protein levels were quantified by 
densitometry using the ImageJ and Gimp software.
T1α Western blot
Murine BAL fluid was centrifuged at 100,000g for 2 hours at 4°C. Pellets were boiled in 
Laemmli buffer and subjected to Western blotting using an antibody directed against Tlα 
(Abeam), as previously described and shown to correlate with alveolar epithelial injury.
RAGE ELISA
RAGE levels in the murine BAL fluid were measured by ELISA (R&D) according to the 
manufacturer’s instructions, as previously described and shown to correlate with epithelial 
injury.
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TUNEL assay
TUNEL staining was performed on lung sections using the In Situ Cell Death Detection Kit 
(Roche) according to the manufacturer’s instructions.
PARP enzyme activity
PARP activity in tissues was measured by an immunohistochemical method assessing PARP 
activity using biotinylated nicotinamide adenine dinudeotide (NAD) (31). Briefly, 
cryosections (10 pm) were fixed in 95% ethanol for 10 min at −20°C and then rinsed in 
PBS. Sections were permeabilized with 1% Triton X-100 in 100 mM tris (pH 8.0) for 15 
min at room temperature. Reaction mixture [10 mM MgCl2, 1 mM dithiothreitol, and 30 μM 
biotinylated NAD+ in 100 mM tris (pH 8.0)] was then applied to the sections for 30 min at 
37°C. Sections incubated with biotinyl-NAD+-free reaction mixture were used as controls. 
After three washes in PBS, incorporated biotin was detected by incubation with a 1:200 
dilution of each of parts A and B of Vectastain Elite ABC kit (Vector Labs) for 90 min at 
room temperature. After three 10-min washes in PBS, color was developed with nickel-DAB 
substrate. Sections were counterstained in Fast Green, dehydrated, and mounted in 
VectaMount.
Data analysis
All statistical analysis was carried out using GraphPad Prism 5.0. All data are expressed as 
means ± SEM, and P < 0.05 was considered statistically significant. For comparison 
between two groups, two-sample t tests were used. In cases of comparison among more than 
two groups, ANOVA with Bonferroni correction for multiple comparison adjustments was 
applied. For all fold change data obtained from real-time quantitative PCR, we took log2 
transformation before performing any statistical analysis. The Mantel-Cox test was used for 
analysis of survival curves. Because the human data derived from BAL fluid were not 
normally distributed (confirmed with D’Agostino-Pearson omnibus test; GraphPad Prism 
5.0), we report the data as median and 25 to 75% percentiles. The data were analyzed using 
a nonparametric analysis (Mann-Whitney test).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Transfer of miR-223 during neutrophil-epithelial cell interactions
(A) Coculture setup for human neutrophils (PMNs) and human pulmonary epithelial cells. 
(B) Expression of miRNA in human epithelial cells after coculture of HPAEpiC with 
activated human PMNs (means ± SEM; n = 4). (C) hsa-miR-223 expression after coculture 
of HPAEpiC with activated human PMNs (means ± SEM; n=6). (D and E) Expression of 
miR-223 in HPAEpiC after exposure of HPAEpiC cells to (D) fMLP or (E) LPS [means ± 
SEM; n=2 for control (Ctr) group or n = 3 for fMLP and LPS groups]. (F) Epithelial cell 
miR-223 target vector luciferase activity after coculture of activated human PMNs with 
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transfected pulmonary epithelial cells (Calu-3); data are normalized to control vector activity 
and compared to no coculture (means ± SEM; n = 3 independent experiments). (G) Setup 
for murine coculture. (H) mmu-miR-223 expression in mouse pulmonary epithelial 
(MLE-12) cells after coculture with activated murine PMNs derived from wild-type (WT) or 
miR-223−/y mice (means ± SEM; n = 11 for the control group, n = 6 for mouse WT PMNs, 
and n = 7 for miR-223−/y PMNs). (I) mmu-miR-223 expression in MLE-12 cells or E-10 
cells after coculture with activated murine PMNs (means ± SEM; n = 7 for MLE-12 control 
group or n = 8 for all other conditions) [*P < 0.05, Student’s t test or analysis of variance 
(ANOVA)]. n.s., not significant.
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Fig. 2. PMN-dependent transfer of miR-223 to human pulmonary epithelial cells
(A) hsa-miR-223 release into human PMN–derived supernatants was compared to culture 
medium only (means ± SEM; n = 4 in the culture medium–only group and n = 6 in the 
PMN-derived supernatant group) after human PMN activation. (B) hsa-miR-223 in PMN 
supernatant–derived microvesicles compared to medium only (means ± SEM; n = 4). (C) 
Expression of miR-223 in HPAEpiC cells after incubation with PMN-derived or control 
supernatants containing microvesicles (+MV) or depleted of microvesicles (−MV) (means ± 
SEM; n = 7). (D) hsa-miR-223 expression after coculture of activated human PMNs with 
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HPAEpiC cells in the presence or absence of the endocytosis inhibitor 
monodansylcadaverine (MDC) (means ± SEM; n = 8). (E) Pulmonary expression of mmu-
miR-223 in a mouse model of VILI (means ± SEM; n = 6 mice per group). (F) mmu-
miR-223 expression in isolated mouse AT-II cells after VILI (means ± SEM; n = 5 mice in 
the control group and n = 6 mice in the VILI group). (G) mmu-miR-223 expression in AT-II 
cells Isolated from a mouse bone marrow (BM) chimera (WT → miR-223−/y and 
miR-223−/y → WT) after exposure to VILI (means ± SEM; n = 5 mice in the WT → 
miR-223−/y VILI group and n = 4 mice in all other groups). (H) mmu-miR-223 expression 
in murine lung tissue during VILI after antibody-mediated depletion of PMNs (means ± 
SEM; n = 5 mice in the control-treated group, n = 4 mice in the 1A8 antibody-treated group, 
and n = 7 mice in the control-treated VILI group). (I) Intravital microscopy of HL-60 cells, 
transfected with a dye-labeled miRNA mimic (red) and labeled with calcein dye (green), 
after intravenous injection into mice ventilated for 30 min (top) or after 90 min of high tidal 
ventilation to induce VILI (bottom) (two representative images; n = 3 mice). (J) 
Immunohistochemical (IHC) costaining of AT-II cells [fluorescein isothiocyanate (FITC)–
pro–surfactant protein C (SPC); green] and Qtracker-labeled and intravenously injected 
HL-60 cells (Qtracker-655; red) in murine lung tissue after induction of VILI (one 
representative image; n = 3 mice). (K) hsa-miR-223 expression in BAL fluid derived from 
patients with ARDS or healthy controls (median and 25 to 75% percentiles; n = 8 controls 
and n = 55 ARDS patients; Table 1) (*P < 0.05, Student’s t test, ANOVA, or nonparametric 
analysis Mann-Whitney test).
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Fig. 3. PARP-1 is a miR-223 gene target in human pulmonary epithelial cells
(A) Baseline hsa-miR-223 expression in lentiviral-transduced, human Calu-3 (lenti-223) 
cells compared to control Calu-3 (lenti-ctr) cells (means ± SEM; n=4). (B) Epithelial cell 
miR-223 target vector luciferase activity in transfected human Calu-3 cells compared to 
control vector activity (means ± SEM; n=6). (C) Analysis of PARP-1 transcripts in 
lentiviral-transduced human Calu-3 cells compared to control Calu-3 cells using real-time 
reverse transcription polymerase chain reaction (RT-PCR) relative to the housekeeping gene 
β-actin (means ± SEM; n = 8). (D and E) Western blot analysis of PARP-1 protein in 
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lentiviral-transduced human Calu-3 cells compared to control Calu-3 cells (one 
representative blot of three is shown; quantification by densitometry, n=3). (F) Schematic of 
luciferase reporter plasmids showing the binding sequence between PARP-1 3′UTR and 
hsa-miR-223. (G and H) Luciferase activities of PARP-1 3′UTR WT plasmid or mutated 
(MUT) plasmid compared to control 3′UTR plasmid after transfection into lentiviral-
transduced human Calu-3 cells (lentl-ctr or lentl-223) (means ± SEM; n=12). (I) PARP-1 
transcripts in the human Calu-3 cell line after coculture with human PMNs measured by 
real-time RT-PCR relative to the housekeeping gene β-actin (means ± SEM; n = 6) (*P < 
0.05; Student’s t test).
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Fig. 4. Acute lung injury in miR-223−/y mice
WT and miR-223−/y mice were exposed to VILI, (A) Albumin detected in mouse BAL fluid 
was measured in WT and miR-223−/y mice (means ± SEM; n=5 mice in the WT control 
group and n=7 mice in all others groups). (B) The neutrophil enzyme myeloperoxidase 
(MPO) was measured in BAL fluid from WT and miR-223−/y mice (means ± SEM; n = 5 
mice in the WT VILI group and n = 6 mice in all others groups). (C and D) Interleukin-6 
(IL-6) and Cxcl-1 protein concentrations in BAL fluid from WT and miR-223−/y mice were 
measured by enzyme-linked immunosorbent assay (ELISA) [means ± SEM; (C) n = 6 mice 
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in the control group, n =13 mice in the WTVILI group, and n = 12 mice in the miR-223−/y 
VILI group; (D) n=6 mice in the control group, n=8 mice in the WTVILI group, and n = 13 
mice in the miR-223−/y VILI group]. (E) Representative slides of pulmonary histology for 
WT and miR-223−/y mice [hematoxylin and eosin (H&E) staining]. Scale bar, 100 μm. (F) 
Scoring of lung injury in slides from (E). (G and H) Pulmonary PARP-1 protein expression 
In WT or miR-223−/y mice at baseline (Ctr) or during acute lung Injury (VILI) relative to the 
housekeeping gene β-actin (one representative blot of three is shown; quantification by 
densitometry, n = 3). (I) PARP-1 enzyme activity in WT or miR-223−/y mice (n = 5 mice in 
the miR-223−/y VILI group or n = 4 mice for all other groups). HPF, high-power field. (J) 
Representative immunohistochemical staining for PARP-1 activity in WT and miR-223−/y 
mice (*P < 0.05, ANOVA).
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Fig. 5. Pulmonary bacterial Infection in miR−/y mice
Pulmonary Infection in miR-223−/y mice (filled circles) and WT mice (empty circles) was 
induced by intratracheal administration of S. aureus. (A) Albumin detected in the BAL fluid 
was measured [(means ± SEM; n = 4 mice in the control group, n = 8 mice in the WT group 
Infected with S. aureus, and n = 6 mice in the miR-223−/y group infected with S. aureus]. 
(B) Myeloperoxidase was measured in BAL fluid from miR-223−/y mice infected with S. 
aureus. IL-6 and Cxcl-1 proteins were measured in BAL fluid using ELISA: (C) IL-6 and 
(D) Cxcl-1 [(B and C) means ± SEM; n = 8 mice in the control group, n = 13 mice in the 
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WT group infected with S. aureus, and n = 11 mice in the miR-223−/y group infected with S. 
aureus; (D) means ± SEM; n = 8 mice in the control group, n = 12 mice in the WT mouse 
group infected with S. aureus, n = 11 mice in the miR-223−/y group infected with S. aureus). 
Transcripts were analyzed in mouse lung tissue for (E) IL-6, (F) IL-1β, and (G) Cxd-1 by 
real-time RF-PCR relative to the housekeeping gene β-actin. [(E) means ± SEM; n = 4 WT 
or miR-223−/y mice in the control groups and n = 7 WT or miR-223−/y mice in the S. aureus 
infection groups; (F and C) means ± SEM; n = 4 WT or miR-223−/y mice in the control 
groups, n = 8 mice in the WT S. aureus infection groups, and n = 7 in the miR-223−/y S. 
aureus infection group]. (H) Survival of WT and miR-223−/y mice after pulmonary infection 
with S. aureus bacteria (n = 9 mice per group). Number of bacterial colony-forming units 
(CFU) 4 hours after infection with intratracheal S. aureus (I) (means ± SEM; n = 8 mice in 
the WT group and n =7 mice in the miR-223−/y group) and in BAL fluid when mice were 
moribund (J) (means ± SEM; n = 7 mice in the WT group and n=9 mice in the miR-223−/y 
group) (*P < 0.05 and §P < 0.05 in the post hoc analysis between WT mice and miR-223−/y 
mice after S. aureus exposure).
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Fig. 6. Genetic knockdown of PARP-1 with shRNA in miR-223−/y mice with acute lung injury
(A and B) Pulmonary PARP-1 protein knockdown in miR-223−/y mice using PARP-1 
shRNA [one representative blot of three is shown; quantification by densitometry in (B), 
means ± SEM; n = 3 mice]. (C) Immunohistochemical staining for pulmonary PARP-1 
activity in miR-223−/y mice treated with Parp-1 shRNA or control shRNA (n = 3 mice). (D) 
Quantification of immunohistochemical staining in (C) [means ± SEM; n = 6 mice in the 
nonventilated control shRNA group, n = 4 in the nonventilated Parp-1 shRNA group, and n = 
10 or 5 mice in the control shRNA or Parp-1 shRNA ventilated (VILI) groups]. (E) Albumin 
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detected In BAL fluid in miR-223−/y mice treated with control or Parp-1 shRNA and 
cytokine concentrations in BAL fluid measured by ELISA (F) IL-6 and (G) Cxcl-1 protein. 
Pulmonary transcripts in miR-223−/y mice treated with control or Parp-1 shRNA for (H) 
IL-6, (I) IL-1β, (J) Cxcl-1, and (K) tumor necrosis factor-α (Tnfα), assessed by RT-PCR 
relative to the housekeeping β-actin gene [(F to K) means ± SEM; n = 4 mice in the control 
groups and n = 5 mice in the VILI groups] (*P < 0.05, ANOVA).
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Fig. 7. Pulmonary overexpression of miR-223 during acute lung injury in WT mice
Nanoparticle-mediated overexpression of mmu-miR-223 in C57BL/6J mice before acute 
lung injury induced by ventilation (VILI). (A) Parp-1 transcripts measured by real-time RT-
PCR relative to the housekeeping gene β-actin in isolated murine AT-II cells before and after 
nanoparticle-mediated delivery of miR-223 mimic (either mimic-control or mimic-223) 
(means ± SEM; n = 5 mice per group). (B) Albumin detection in murine BAL fluid was 
assessed by ELISA in nanoparticle-treated WT mice (nanoparticles contained either 
miR-223 mimic or control mimic; means ± SEM; n = 7 mice in the control groups and n = 
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11 mice in the acute lung injury groups). (C) Lung wet–to–dry weight ratio of nanoparticle-
treated murine lungs at baseline and after acute lung injury induced by ventilation (VILI) 
(means ± SEM; n = 4 mice per group). (D and E) IL-6 and Cxcl-1 protein concentrations in 
murine BAL fluid were assessed by ELISA (D) means ± SEM; n = 5 mice in the control 
groups and n = 9 mice in the acute lung injury VILI groups; (E) means ± SEM; n = 4 mice 
in the control groups and n = 9 or 10 mice in the mimic-223- or mimic-control–treated VILI 
groups]. (F) Representative slides of mouse pulmonary histology before and after treatment 
with nanoparticles containing miR-223 mimic (mimic-223) or control mimic (H&E 
staining). Scale bar, 100 μm. (G) Scoring of lung injury in histological sections in (F). (H to 
J) Pulmonary transcripts were assessed by real-time RT-PCR relative to the housekeeping 
gene β-actin for (H) IL-6, (I) Cxcl1, and (J) Tnfα [means ± SEM; n = 4 mice in the mimic-
control–treated groups and n = 5 mice in the mimic-223–treated groups for (H); n = 4 mice 
in the mimic-control-treated groups and n = 3 and 5 mice in the mimic-223–treated groups 
for (I); n = 4 and 5 mice in the mimic-control–treated groups and n = 3 and 6 mice in the 
mimic-223–treated groups for (J)] (*P < 0.05 and §P < 0.05 in the post hoc analysis between 
“mimic-ctr"–treated and “mimic-223”–treated mice after VILI, Student's t test or ANOVA).
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Fig. 8. Pulmonary bacterial infection in C57BL/6J mice overexpressing miR-223
After treating C57BL/6J mice with nanoparticles that contained either mimic-223 or mimic-
control, mouse lungs were infected with S. aureus intratracheally. (A) Albumin detected in 
BAL fluid after S. aureus infection and nanoparticle treatment was measured by ELISA 
(means ± SEM; n = 5 mice per group). (B) Myeloperoxidase was measured in BAL fluid 
after S. aureus infection and nanoparticle treatment by ELISA (means ± SEM; n = 7 and 5 
mice in the control groups and n = 10 mice in the S. aureus infection groups). Protein 
concentrations of (C) IL-6 and (D) Cxcl-1 were assessed by ELISA in control and S. 
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aureus–infected C57BL/6J mice [(C and D) means ± SEM; n = 5 mice in the control groups 
and n = 10 mice in the S. aureus infection groups]. Mouse lung tissue was analyzed for (E) 
IL-6 and (F) IL-1β transcripts by real-time RT-PCR relative to the housekeeping gene β-
actin [means ± SEM; (E) n = 9 mice in the mimic-control–treated group and n = 10 mice in 
the mimic-223-treated group; (F) n = 10 mice per group]. (G) Representative slides showing 
pulmonary histology for S. aureus–infected WT mice overexpressing miR-223 (mimic-223) 
or control mimic (H&E staining). Scale bar, 100 μm (means ± SEM; n = 5). (H) Mouse 
survival after pulmonary Infection with S. aureus with or without treatment with 
nanoparticles containing miR-223 mimic or control mimic (n = 15 mice per group). (I) Lung 
bacterial colony-forming units 4 hours after infection of mice with intratracheal S. aureus 
and treated with nanoparticles containing miR-223 mimic or control mimic (means ± SEM; 
n = 5) (*P < 0.05, Student’s t test ANOVA, or Mantel-Cox test).
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